Cautionary Statement Regarding Forward-Looking Statements This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) about retatrutide as a potential treatment for adults with type 2 diabetes and obesity or overweight and adults with severe obesity and established cardiovascular disease, and the timeline for future readouts, presentations and other milestones relating to retatrutide and its clinical trials and reflects Lilly's current beliefs and expectations
Discontinuation data support that reading
The vial arrives, a small container holding a delicate, lyophilized powder packed with possibility
This can worsen GLP-1 side effects digestion concerns
As the Food and Drug Administration cracks down on compounded versions of popular weight loss drugs Wegovy (semaglutide) and Zepbound (tirzepatide), Americans who rely on these cheaper medications may be drawn to a dicey sector of the dietary supplement market
Research into glucagons metabolic role has long established its capacity to stimulate hepatic glycogenolysis and gluconeogenesis, but more recent work highlights its effects on lipid metabolism and thermogenesis